Skip to main content
Tech.euFundingExplorerBeta

Embion Technologies

Embion specializes in the efficient extraction of naturally-derived prebiotics for microbiome nutrition.

Embion Technologies has raised €4.5M across 2 funding rounds from 2 investors, most recently a Series A round in Dec 2021. Based in Ecublens, Switzerland; founded 2016; active in Agritech. Data as of 28 Oct 2026.

Ecublens, SwitzerlandFounded 2016www.embiontech.com ↗
Total raised
€4.5M
€4,546,772
Funding rounds
2
Investors
2
distinct backers
Active since
2020-10
latest 2021-12

Funding by year

EUR raised per year
Embion Technologies — funding by year — interactive chart.
Data table
Embion Technologies — funding by year
2020€233k
2021€4.3M

Signals

High confidence
Raise-next likelihood9
base rate 44% for Series A
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
  • ▲ 10y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2021-12-08Series A€4.3MASAHI Group HoldingsView deal →
2020-10-21Grant€233kALCEA FoundationView deal →

Similar companies

same sector or country

Global coverage: FundingData